Hepatitis viruses take advantage of traditional practices to increase the burden of hepatocellular carcinoma in Tunisia

[1]  R. Bruno,et al.  Update of the statements on biology and clinical impact of occult hepatitis b virus infection. , 2019, Journal of hepatology.

[2]  D. Thorburn,et al.  Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease. , 2019, Journal of hepatology.

[3]  M. Mosli,et al.  Epidemiology and clinical features of patients with hepatocellular carcinoma at a tertiary hospital in Jeddah , 2017, Nigerian journal of clinical practice.

[4]  C. Tovo,et al.  Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study , 2016, World journal of gastroenterology.

[5]  P. Pineau,et al.  Eastern region represents a worrying cluster of active hepatitis C in Algeria in 2012 , 2016, Journal of medical virology.

[6]  S. Alavian,et al.  Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review , 2016, Hepatitis monthly.

[7]  M. ShawkiShereen,et al.  Increased DNA damage in hepatitis C virus-related hepatocellular carcinoma. , 2014 .

[8]  E. Azhar,et al.  Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. , 2014, World journal of gastroenterology.

[9]  Ashish Kumar,et al.  Treatment Response Evaluation and Follow-up in Hepatocellular Carcinoma. , 2014, Journal of clinical and experimental hepatology.

[10]  M. Dollinger,et al.  Epidemiologie und Risikofaktoren des hepatozellulären Karzinoms , 2014, Der Radiologe.

[11]  C. Saitta,et al.  Occult hepatitis B virus and hepatocellular carcinoma. , 2014, World journal of gastroenterology.

[12]  Rebeca García‐Román,et al.  Occult HBV Infection: A Faceless Enemy in Liver Cancer Development , 2014, Viruses.

[13]  N. Zayed,et al.  Increased DNA damage in hepatitis C virus-related hepatocellular carcinoma. , 2014, DNA and cell biology.

[14]  T. Kaçan,et al.  Multicenter epidemiologic study on hepatocellular carcinoma in Turkey. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[15]  T. Helmberger,et al.  Hepatozelluläres Karzinom , 2014, Der Radiologe.

[16]  A. Cucchetti,et al.  Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it? , 2013, World journal of gastroenterology.

[17]  S. Mejri,et al.  Subtyping genotype 2 hepatitis C viruses from Tunisia: identification of two putative new subtypes , 2013, Virus Genes.

[18]  A. Alibrandi,et al.  Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C. , 2013, Journal of hepatology.

[19]  G. Dore,et al.  Epidemiology and natural history of HCV infection , 2013, Nature Reviews Gastroenterology &Hepatology.

[20]  Sahil Mittal,et al.  Epidemiology of hepatocellular carcinoma: consider the population. , 2013, Journal of clinical gastroenterology.

[21]  Jiayin Yang,et al.  Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma. , 2013, World journal of gastroenterology.

[22]  M. Kew.  Epidemiology of hepatocellular carcinoma in sub-Saharan Africa. , 2013, Annals of hepatology.

[23]  S. Trabelsi,et al.  [Epidemiological, clinical and therapeutic features of hepatocellular carcinoma in cirrhotic patients]. , 2012, La Tunisie medicale.

[24]  M. Vergara,et al.  Factors related to survival in hepatocellular carcinoma in the geographic area of Sabadell (Catalonia, Spain). , 2012, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[25]  A. Olmez,et al.  Clinicopathological characteristics of hepatocellular carcinoma in Turkey. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[26]  Chien-Jen Chen,et al.  Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  P. Pineau,et al.  First multicenter study for risk factors for hepatocellular carcinoma development in North Africa. , 2011, World journal of hepatology.

[28]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[29]  Junji Furuse,et al.  The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. , 2010, The oncologist.

[30]  M. Bernardi,et al.  Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections. , 2010, European journal of cancer.

[31]  R. Bataller,et al.  Cigarette smoking and chronic liver diseases , 2010, Gut.

[32]  V. Peinado,et al.  Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats , 2010, Hepatology.

[33]  H. Elloumi,et al.  Management of the hepatocellular carcinoma. , 2009, La Tunisie medicale.

[34]  Elsayed I Salim,et al.  Cancer epidemiology and control in the arab world - past, present and future. , 2009, Asian Pacific journal of cancer prevention : APJCP.

[35]  S. Bhattacharya,et al.  Analysis of hepatitis B virus X gene phylogeny, genetic variability and its impact on pathogenesis: implications in Eastern Indian HBV carriers. , 2008, Virology.

[36]  K. Chayama,et al.  Risk Factors for Hepatocellular Carcinoma in a Japanese Population: A Nested Case-Control Study , 2008, Cancer Epidemiology Biomarkers & Prevention.

[37]  B. Debuire,et al.  New perspectives and strategy research biomarkers for hepatocellular carcinoma , 2007, Clinical chemistry and laboratory medicine.

[38]  P. Pineau,et al.  Genomic stability prevails in North-African hepatocellular carcinomas. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[39]  B. Bell,et al.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.

[40]  C. Bréchot,et al.  Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis , 2006, Oncogene.

[41]  M. Levrero.  Viral hepatitis and liver cancer: the case of hepatitis C , 2006, Oncogene.

[42]  Cesar Yaghi,et al.  Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival. , 2004, World journal of gastroenterology.

[43]  M. Mohamed,et al.  Hepatocellular carcinoma in Egypt: a single center study over a decade. , 2005, World journal of gastroenterology.

[44]  R O Morgan,et al.  Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study , 2005, Gut.

[45]  Xiao-li Feng,et al.  Tight association of hepatocellular carcinoma with HBV infection in North China. , 2005, Hepatobiliary & pancreatic diseases international : HBPD INT.

[46]  K. McGlynn,et al.  Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. , 2004, Gastroenterology.

[47]  J. Allain.  Occult hepatitis B virus infection. , 2004, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[48]  J. Goedert,et al.  The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa , 2004, Hepatology.

[49]  C. Yurdaydın,et al.  Risk Factors for Hepatocellular Carcinoma in Turkey , 2001, Digestive Diseases and Sciences.

[50]  D. Häussinger,et al.  [Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany]. , 2002, Deutsche medizinische Wochenschrift.

[51]  H. El‐Serag,et al.  Extrahepatic manifestations of hepatitis C among United States male veterans , 2002, Hepatology.

[52]  H. El‐Serag.  Hepatocellular carcinoma and hepatitis C in the United States , 2002, Hepatology.

[53]  Manal M. Hassan,et al.  Rising Prevalence of Hepatitis C Virus Infection Among Patients Recently Diagnosed With Hepatocellular Carcinoma in the United States , 2002, Journal of Clinical Gastroenterology.

[54]  M. Chevallier,et al.  High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. , 2001, Journal of hepatology.

[55]  M. Law,et al.  Modelling the hepatitis C virus epidemic in Australia. Hepatitis C Virus Projections Working Group. , 1999, Journal of gastroenterology and hepatology.

[56]  O. Hino,et al.  Hepatitis C Virus and Hepatocarcinogenesis , 1999, Intervirology.

[57]  A. Valleron,et al.  Modeling the hepatitis C virus epidemic in france , 1999, Hepatology.

[58]  F. X. Bosch,et al.  Epidemiology of Primary Liver Cancer , 1999, Seminars in liver disease.

[59]  H. Triki.  [Epidemiology of hepatitis B virus, hepatitis C virus and Delta virus in the general population and in liver cirrhosis in Tunisia]. , 1994, Archives de l'Institut Pasteur de Tunis.

[60]  B. Conne,et al.  Histopathologic features of hepatocellular carcinoma in Zaire , 1990, Cancer.

[61]  I. Fujimoto,et al.  Changing incidence of hepatocellular carcinoma in Japan. , 1987, Cancer research.

[62]  P. Coursaget,et al.  Epidemiology of primary hepatocellular carcinoma in Senegal. , 1981, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

[63]  K. Nørredam.  Primary carcinoma of the liver in Malawi: a review of 24 cases. , 1977, Tropical and geographical medicine.